Catalyst Wire Dossier Catalyst Wire Dossier

irbesartan + amlodipine combination

· Handok Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for irbesartan + amlodipine combination, covering 2023-08-18 to 2023-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients [Phase 3]

See pricing